Evidence map›Paper›PMID 27511733›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Systems Analysis of the Complement-Induced Priming Phase of Liver Regeneration.

Jun S Min, Robert A DeAngelis, Edimara S Reis, Shakti Gupta, Mano R Maurya, Charles Evans, Arun Das, Charles Burant, John D Lambris, Shankar Subramaniam

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Orosomucoid in liver diseases.World journal of gastroenterology · 2021
    Article
  6. Article
  7. Review
  8. Review
  9. The Dynamic Chromatin Architecture of the Regenerating Liver.Cellular and molecular gastroenterology and hepatology · 2020
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jun S MinDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093;ORCID 0000-0001-6380-3351
Robert A DeAngelisDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Edimara S ReisDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;ORCID 0000-0002-8438-275X
Shakti GuptaDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093;
Mano R MauryaDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093;ORCID 0000-0003-4249-067X
Charles EvansDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI 48109;ORCID 0000-0001-6698-5330
Arun DasDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI 48109;ORCID 0000-0002-0883-1816
Charles BurantDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI 48109;ORCID 0000-0001-9189-5003
John D LambrisDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; shankar@ucsd.edu lambris@upenn.edu.
Shankar SubramaniamGraduate Program in Bioinformatics, Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA 92093; Department of Bioengineering, Institute of Engineering in Medicine, University of California, San Diego, La Jolla, CA 92093; Department of NanoEngineering, University of California, San Diego, La Jolla, CA 92093; and Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093 shankar@ucsd.edu lambris@upenn.edu.ORCID 0000-0002-8059-4659
University of California San Diego · USUniversity of Michigan · USUniversity of Pennsylvania · US

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
Systems Biology Analyses for Hemodynamic Regulation of Vascular HomeostasisR01HL108735 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHIEN, SHU, SHYY, JOHN YJ · 2012 to 2024
$13.4M
Statistics and Bioinformatics Core - WangU24DK097153 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BURANT, CHARLES F · 2012 to 2017
$10.1M
Shear Regulation of MicroRNA Transportomes and Targetomes in Vascular HomeostasisR01HL106579 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHIEN, SHU, SHYY, JOHN YJ · 2011 to 2022
$8.3M
The Metabolomics Data Center and Workbench (MDCW)U01DK097430 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANIAM, SHANKAR · 2012 to 2017
$7.4M
NHLBI NIH HHS R01 HL106579NHLBI NIH HHS R01 HL108735NIAID NIH HHS P01 AI068730NIDDK NIH HHS U01 DK097430NIDDK NIH HHS U24 DK097153
6 · The paper itself

Abstract

Liver regeneration is a well-orchestrated process in the liver that allows mature hepatocytes to reenter the cell cycle to proliferate and replace lost or damaged cells. This process is often impaired in fatty or diseased livers, leading to cirrhosis and other deleterious phenotypes. Prior research has established the role of the complement system and its effector proteins in the progression of liver regeneration; however, a detailed mechanistic understanding of the involvement of complement in regeneration is yet to be established. In this study, we have examined the role of the complement system during the priming phase of liver regeneration through a systems level analysis using a combination of transcriptomic and metabolomic measurements. More specifically, we have performed partial hepatectomy on mice with genetic deficiency in C3, the major component of the complement cascade, and collected their livers at various time points. Based on our analysis, we show that the C3 cascade activates c-fos and promotes the TNF-α signaling pathway, which then activates acute-phase genes such as serum amyloid proteins and orosomucoids. The complement activation also regulates the efflux and the metabolism of cholesterol, an important metabolite for cell cycle and proliferation. Based on our systems level analysis, we provide an integrated model for the complement-induced priming phase of liver regeneration.

Indexed as

Complement ActivationAnimalsCell ProliferationCholesterolComplement C3Gene Expression ProfilingHepatectomyHepatocytesLiver RegenerationMetabolomicsMiceMice, Inbred C57BLOrosomucoidSerum Amyloid A ProteinTumor Necrosis Factor-alphaCholesterolComplement C3OrosomucoidSerum Amyloid A ProteinTumor Necrosis Factor-alpha

Identifiers

PMID27511733
PMCPMC5038987
OpenAlexW2486731395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.